Skip to main content
PLOS One logoLink to PLOS One
. 2022 Mar 31;17(3):e0266343. doi: 10.1371/journal.pone.0266343

The effect of COVID-19 on public hospital revenues in Iran: An interrupted time-series analysis

Masoud Behzadifar 1,*, Afshin Aalipour 1, Mohammad Kehsvari 2, Banafsheh Darvishi Teli 2, Mahboubeh Khaton Ghanbari 3, Hasan Abolghasem Gorji 3, Alaeddin Sheikhi 2, Samad Azari 4, Mohammad Heydarian 5, Seyed Jafar Ehsanzadeh 6, Jude Dzevela Kong 7, Maryam Ahadi 8, Nicola Luigi Bragazzi 7
Editor: Edris Hasanpoor9
PMCID: PMC8970352  PMID: 35358279

Abstract

Background

The “Coronavirus Disease 2019” (COVID-19) pandemic has become a major challenge for all healthcare systems worldwide, and besides generating a high toll of deaths, it has caused economic losses. Hospitals have played a key role in providing services to patients and the volume of hospital activities has been refocused on COVID-19 patients. Other activities have been limited/repurposed or even suspended and hospitals have been operating with reduced capacity. With the decrease in non-COVID-19 activities, their financial system and sustainability have been threatened, with hospitals facing shortage of financial resources. The aim of this study was to investigate the effects of COVID-19 on the revenues of public hospitals in Lorestan province in western Iran, as a case study.

Method

In this quasi-experimental study, we conducted the interrupted time series analysis to evaluate COVID-19 induced changes in monthly revenues of 18 public hospitals, from April 2018 to August 2021, in Lorestan, Iran. In doing so, public hospitals report their earnings to the University of Medical Sciences monthly; then, we collected this data through the finance office.

Results

Due to COVID-19, the revenues of public hospitals experienced an average monthly decrease of $172,636 thousand (P-value = 0.01232). For about 13 months, the trend of declining hospital revenues continued. However, after February 2021, a relatively stable increase could be observed, with patient admission and elective surgeries restrictions being lifted. The average monthly income of hospitals increased by $83,574 thousand.

Conclusion

COVID-19 has reduced the revenues of public hospitals, which have faced many problems due to the high costs they have incurred. During the crisis, lack of adequate fundings can damage healthcare service delivery, and policymakers should allocate resources to prevent potential shocks.

Introduction/Background

The still ongoing “Coronavirus Disease 2019” (COVID-19) has become a major challenge for all healthcare systems worldwide, and, besides generating a high toll of deaths, it has caused extensive economic damage and losses [1]. All social, political, cultural and economic activities have been affected both nationally and internationally [2]. Despite widespread efforts to control COVID-19, unfortunately, many people have lost their lives and measures and interventions to prevent and control the disease are still being enforced, with only a few countries getting back to the normal [3]. Since the beginning of the outbreak, countries around the world have adopted various policies and programs to combat the disease, including quarantine, social distancing, lockdown, closure of schools and universities, and restrictions of air, land, and sea borders [4,5].

All actors and parts of the health system in different countries are involved to prevent, control and reduce mortality induced by COVID-19 [6]. Since the beginning of the COVID-19, hospitals have played a very important role in providing services to patients and the volume of hospital activities and healthcare provisions delivered has been significantly refocused on COVID-19 patients [7]. Due to the need of these patients to receive services, many activities of other hospitals have been limited, repurposed, or even suspended and, as such, they operate with reduced capacity. Non-critical medical services and elective surgeries have been generally postponed [8]. Due to the rapid spread of the disease and the increase in infections, the capacity of some parts of the hospital, such as the intensive care unit, is being saturated or is reaching a critical threshold [9]. Hospitals have changed some of their care and management protocols to deal with this situation, and, for instance, hospital managers have closed outpatient wards and suspended some hospital activities [10]. On the other hand, with the reduction of these activities, the financial system of the hospitals and their sustainability are seriously threatened and the hospitals may face a shortage of their revenues and financial resources [11]. Hospitals need adequate economic funding to provide the needed healthcare services, and to ensure continuity of care, and, especially in critical situations such as the current COVID-19, new financial resources are needed. Health decision-makers and policymakers must pay attention to the financial resources of hospitals to avoid reducing the provision and quality of services [12].

In February 2020, the Ministry of Health and Medical Education (MOHME) in Iran publicly announced the emergence of COVID-19 in Iran when the first cases of the disease were observed [4]. According to the MOHME report, as of January 1, 2022, out of a population of about 84 million in Iran, 61,954,033 people were infected with COVID-19, among whom 131,639 lost their lives due to the COVID infection. Regarding vaccination, a population of about 60 million received their first dose of the COVID-19 vaccine, 51 million received the second dose, and also 8 million received the third dose of the vaccine [13].

The MOHME, in collaboration with other organizations and ministries, implemented various policies and programs to prevent and control the COVID-19 pandemic [14]. Due to the high prevalence rate of the disease, and the influx of large numbers of people, hospitals have been providing full capacity services, especially to COVID-19 patients [15].

In the Iranian health system, services are provided in both the public and private sectors. All primary health care is provided free of charge by government centers [16]. In public hospitals, all services are provided based on government tariffs as well as patients’ insurance. In these hospitals, the government has tried to keep the out-of-pocket (OOP) population low [17]. Also, private hospitals provide services based on free tariffs. The services provided in public and private hospitals are more or less the same, and people can use the services of private hospitals according to their interests [18]. The most important difference between public and private hospitals is the costs that people pay; in private hospitals in Iran, the cost of receiving services is considerably high [19].

COVID-19 has had a huge impact on the world economy, and the health financial sector has been affected and disrupted by the disease. Therefore, many governments have made extensive investments in the healthcare sector, allocating important financial resources to counteract or at least mitigate the reduction in service delivery and meet the needs of individuals [20]. In Iran, too, the government has sought to address the shortcomings of COVID-19 by injecting resources [4]. Although economic sanctions have made things difficult, the Iranian government is working to ensure that the health sector, and especially hospitals, do not suffer from a lack of funding [14]. The government injected financial aid into hospitals during the pandemic. In this regard, at the beginning of the pandemic, there was a shortage of personal protective equipment in hospitals; thus, MOHME purchased the equipment and made it available to hospitals [21]. More funding was also injected to high-prevalence provinces, and hospitals suffering from shortages of ICU beds. Meanwhile, funds were allocated for the purchase of oxygen generators and the drugs needed to fight the disease. In addition, funding was allocated to medical universities to be spent according to local priorities [22].

A large part of the healthcare services and equipment that hospitals pay for their activities is based on their revenues, and any reduction in revenues can, therefore, affect the provision of services. Studying the economic impact of COVID-19 can help health policymakers and decision-makers allocate resources and provide the funding they need and come up with plans to address revenue cuts if needed, in an evidence- and data-driven fashion. The aim of this study was to investigate the effect of COVID-19 on the revenues of public hospitals in Lorestan province in western Iran, as a case study.

Method

Ethics declarations

The ethics committee of the Lorestan University of Medical Sciences approved this study (approval code no. IR.LUMS. REC.1399.083).

Setting

Lorestan province is located in western Iran and its population is about 1,700,000 people. Lorestan University of Medical Sciences (LUMS) is the main custodian of health services in the province and the primary health care centers and public hospitals are under its supervision and carry out their activities. There are 18 public hospitals in the province.

Study design

This is a quasi-experimental study performed using interrupted time series analysis (ITSA). We performed an ITSA to evaluate changes in monthly revenue of the public hospitals due to COVID-19. Policymakers are interested in evaluating the impact of different policies in the health sector and, depending on the effects, decide whether to continue or not their implementation [23]. ITSA is widely used to monitor and track the effectiveness of both clinical and non-clinical interventions and can help provide evidence for decision-making [24]. ITSA examines a continuous time series of observations on an outcome repeatedly over time [25]. At ITSA, we seek to understand the effects of implementing a policy or intervention on a topic by comparing before and after, and this can lead to a better understanding of the policy [26]. In health-related crises such as COVID-19, ITSA can assess the consequences of implementing different policies in these situations and help managers make effective decisions [15].

Data collection

The monthly revenue was collected from April 2018 to August 2021. The revenue of 18 public hospitals was provided by LUMS financial center; two researchers (MB, MA) were referred to this data center in order to collect the data. Also, public hospitals collect their revenues monthly and report them to the LUMS financial center. In all public hospitals, the revenue department is responsible for collecting all costs, as well as determining activities related to insurance, drug price control, activities related to increasing incomes, providing hospital deductions, and OOP patients.

Statistical analysis

We used a segmented regression model for ITSA [27]. The Newey‐West approach was used for estimating the best analytical approach [28]. We conducted several diagnostic and sensitivity assessments to assess the robustness of our findings [29]. The ordinary least squares (OLS) regression model with a time series specification was utilized to check for serially correlated errors using the Durbin-Watson test. Also, we used visualization of the residuals from the OLS regression and plots of the autocorrelation and partial autocorrelation graphs [25]. The R software Version 3.6.1 (London, UK) was used for all statistical analyses. P-value < 0.05 was considered significant.

Results

At the beginning of the pandemic, the average revenue of public hospitals was $460,311 thousand which began to decline with the emergence of COVID-19 in Iran. Fig 1 shows that after the onset of COVID-19 and the provision of health services under the new conditions, the general revenue of public hospitals has been associated with an average monthly decrease of $172,636 thousand. Immediately after the emergence of COVID-19, we observed a statistically significant change in hospital revenue. For about 13 months, the trend of declining hospital revenues has continued; however, after February 2021, we observed a relatively stable increase.

Fig 1. The temporal trend of the revenue rate for public hospitals.

Fig 1

This decrease in income was statistically significant (P-value = 0.01232). The findings from the segmented regression model shows in Table 1.

Table 1. The coefficients of the segmented regression model after Covid-19 in the public hospitals.

Variable Value P-Value Lower of CI (95%) Upper of CI (95%)
Intercept 460311 0.000 367319.47 553302.285
Time -9850 0.00769 -16930.65 -2770.155
Level -172636 0.01232 -305558.89 -39712.465
Trend 25186 0.000 13871.47 36499.516

Return to normal conditions in hospitals

From February 2021, patient admission and selective surgeries restrictions were lifted. To assess the impact of this policy, we conducted an ITSA and analyzed the data from August 2020 to August 2021. As time passes, revenues increased, at the beginning of the hospitals’ activities, the average income was $101,565 thousand. Then the average income of hospitals has experienced a monthly increase of $83,574 thousand (Fig 2). The findings from the segmented regression model after returning to normal conditions in hospitals are shown in Table 2. The autocorrelation and partial autocorrelation plots of the residuals are also reported in Fig 3A (after COVID-19 in the public hospitals) and 3B (rate after returning to normal condition in hospitals). To ensure the stability of the findings in different stages of data analysis, we conducted a sensitivity analysis and were able to confirm the stability of the findings.

Fig 2. The temporal trend of the revenue rate after return to normal conditions in hospitals.

Fig 2

Table 2. The coefficients of the segmented regression model after return to normal conditions in hospitals.

Variable Value P-Value Lower of CI (95%) Upper of CI (95%)
Intercept 101565 0.291 -103400.41 306529.49
Time 18301 0.452 -34329.68 70930.60
Level 83574 0.460 62553.80 96406.16
Trend 31767 0.312 35323.84 98857.22

Fig 3. Autocorrelation and partial autocorrelation function.

Fig 3

Discussion

Findings of our study revealed that after the emergence of COVID-19 in Iran, revenues of public hospitals in Lorestan province have dramatically and significantly decreased.

At the onset of COVID-19 and with the increasing prevalence of the disease, many people refused to go to hospitals for fear of infection and illness. Even if they needed to receive services in hospitals, they did not seek for medical advice, and the number of outpatient visits decreased dramatically. For better management of patients with COVID-19, selected hospital wards and units were allocated to these patients, but nevertheless, fear of the disease prevailed in the community. In many countries, hospitals had no choice but to provide more beds for patients with COVID-19, which resulted in fewer beds available for non-COVID-19 patients and decreased hospital revenues [30,31].

Kazempour-Dizaji’s study showed that COVID-19 decreased hospital revenues by 9%, which is consistent with our findings (32). Khullar’s study showed that the reduction in outpatient visits, due to fears of COVID-19, has been effective in reducing hospital service capacity [10].

Due to declining referrals and a sharp reduction in hospital activities, hospital managers were forced to reduce outpatient admissions, and even in some hospitals, these services were completely discontinued. Also, elective and non-emergency surgeries were completely stopped. Because of the need for more medical specialists in most hospitals to manage patients with COVID-19 and because of the possibility of transmitting the infection to non-Covid-19 patients, they were reluctant to undergo elective surgery. People who had elective surgery did not go to hospitals because of the lack of these services, and as a result, many revenues related to these services in hospitals decreased.

Decreased admissions and elective surgeries have been cited in studies as one of the reasons for the decline in revenue, and one of the main reasons for this change in revenue was MOHME’s decision to turn hospitals into special centers for the treatment of COVID-19 patients and virtually no other services [32]. In the study by Bai et al., reducing hospital visits and canceling elective surgeries caused by COVID-19 decreased hospital revenues and is consistent with our findings [33]. Hospitals are unable to pay for their own expenses, especially the salaries of their staff, and face many financial problems.

On the other hand, some hospital managers, due to lack of manpower and their fatigue, reduced the admission of unnecessary patients [34]. Even in the early stages of the disease, hospitals that were not COVID-19 dedicated centers reduced patient admissions to prevent transmission of the disease to their staff. Other studies have pointed to such reasons and called for policymakers to address hospital problems, especially financial challenges [30].

The Government of Iran, in order to effectively prevent and control COVID-19, started implementing a policy of social distancing on March 27th, 2020. It also imposed severe restrictions on the presence of members of the community in various activities. Many people, for fear of fines and uncertainty about the implementation of social distance in hospitals, was one of the reasons for the decline in hospitalization for services [15].

Early in the onset of the disease in Iran, there was no specific treatment protocol for patients in hospitals, and MOHME stated that all costs of the disease were free of charge and that patients did not incur any out-of-pocket payments. The insurance companies strongly opposed this decision and did not accept the medical services provided to the patients, and the hospitals had to cope with many insurance deductions [34].

Our findings show that after 13 months, and from March 2021 on, the trend of increasing revenues of public hospitals in Lorestan province began. With the experience that hospitals gained over the months in connection with COVID-19, new policies and programs were adopted to generate revenue for public hospitals and to prevent bankruptcy. All public hospitals set up special wards and units for COVID-19 patients. Meanwhile, all hospitals began to get back to normal and started admitting different patients, and the admission restrictions were also lifted. Policies shifted toward accepting all recipients of services (either COVID-19 or non-COVID-19 patients), and the scope of hospital activities became the same as prior to COVID-19 outbreak. This policy change resulted in an increase in patients, with activities almost returned to normal.

The terrible fear existing from the beginning of the COVID-19 outbreak slowly declined, and many patients gradually came to the conclusion that it would be safe to visit hospitals while wearing masks and observing social distance. Alongside, doctors started admitting patients due to declining revenues, and hospitals increased selective surgery.

Another reason for the increase in revenues in public hospitals was the increase in safety equipment in hospitals. Hospital staff used safety equipment to provide services more safely to the public. However, their lack of safety equipment and facilities made them suffer for months, and they could not provide services to many people as usual for fear of transmitting the disease.

There is no credible scientific evidence for treating COVID-19. At present, and in recent months, due to the use of some drugs such as Remdesivir and Favipiravir for the treatment of patients, as well as the increased speed of the COVID-19 vaccination roll-out program, and the clarification of patients’ treatment protocols, insurers have covered the provided services. Also, insurance reimbursements and cooperation of insurers with hospitals increased revenues.

Despite the fact that the range of activities and services provided by three private hospitals in Lorestan province is limited, and due to patients’ fear of being infected with COVID-19, some patients still visited these hospitals to receive services.

Limitations

This study has some limitations. Due to the lack of accurate infrastructure and facilities in collecting data on all revenues and expenditures, access to revenue breakdown in terms of single components was not possible; thus, we were unable to analyze all revenue components. Meanwhile, there was not enough information to analyze the role of each hospital ward and its impact on revenues. Also, we did not have access to the revenues of private hospitals. A comparison of public and private hospitals on their revenues could help understand the behavioral pattern of patients receiving services in these hospitals. In addition, cultural differences and conditions in which services are provided in hospitals in Lorestan province can be different from other provinces.

Conclusion

The findings of this study demonstrate that COVID-19 has dramatically and significantly reduced the revenues of public hospitals, which have faced with many problems due to the high costs they have incurred. As an emerging pathogen, with destructive effects on the economy of the whole world, COVID-19 has led to staggering costs on the health sector. Many hospitals were unable to cope with COVID-19 due to lack of financial resources and declining revenues. To prevent the decline in the quality of services in hospitals, governments had to inject new financial resources into hospitals. In times of crisis, lack of adequate fundings in the health sector can cause irreparable damage to healthcare service delivery; thus, policymakers should allocate adequate funding in order to prevent potential shocks from a pandemic like COVID-19.

Supporting information

S1 Data

(XLSX)

Abbreviations

MOHME

Ministry of Health and Medical Education

ITSA

Interrupted time series analysis

OLS

Ordinary least squares

OOP

Out-of-pocket

Data Availability

Data are available upon request to the Corresponding Author and the Ethics Committee of the Lorestan University of Medical Sciences (email: research@lums.ac.ir; tel: 00986633120172); since they may contain potentially sensitive information and are owned by a third-party organization (Lorestan University of Medical Sciences, Iran).

Funding Statement

The author(s) received no financial support for the research, authorship, and/or publication of this article.

References

  • 1.Singh DR, Sunuwar DR, Shah SK, Karki K, Sah LK, Adhikari B, et al. Impact of COVID-19 on health services utilization in Province-2 of Nepal: a qualitative study among community members and stakeholders. BMC Health Serv Res. 2021;21(1):174. doi: 10.1186/s12913-021-06176-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ghaffari Darab M, Keshavarz K, Sadeghi E, Shahmohamadi J, Kavosi Z. The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran. BMC Health Serv Res. 2021;21(1):132. doi: 10.1186/s12913-021-06126-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92(4):401–2. doi: 10.1002/jmv.25678 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Behzadifar M, Ghanbari MK, Bakhtiari A, Behzadifar M, Bragazzi NL. Ensuring adequate health financing to prevent and control the COVID-19 in Iran. Int J Equity Health. 2020;19(1):61. doi: 10.1186/s12939-020-01181-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Morlock R, Morlock A, Downen M, Shah SN. COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders. PLoS One. 2021;16(1):e0245586. doi: 10.1371/journal.pone.0245586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Barasa E, Kazungu J, Orangi S, Kabia E, Ogero M, Kasera K. Indirect health effects of the COVID-19 pandemic in Kenya: a mixed methods assessment. BMC Health Serv Res. 2021;21(1):740. doi: 10.1186/s12913-021-06726-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dopfer C, Wetzke M, Zychlinsky Scharff A, Mueller F, Dressler F, Baumann U, et al. COVID-19 related reduction in pediatric emergency healthcare utilization—a concerning trend. BMC Pediatr. 2020;20(1):427. doi: 10.1186/s12887-020-02303-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Abebe W, Worku A, Moges T, Tekle N, Amogne W, Haile T, et al. Trends of follow-up clinic visits and admissions three-months before and during COVID-19 pandemic at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia: an interrupted time series analysis. BMC Health Serv Res. 2021;21(1):731. doi: 10.1186/s12913-021-06730-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.White DB, Lo B. A Framework for Rationing Ventilators and Critical Care Beds During the COVID-19 Pandemic. JAMA. 2020;323(18):1773–4. doi: 10.1001/jama.2020.5046 [DOI] [PubMed] [Google Scholar]
  • 10.Khullar D, Bond AM, Schpero WL. COVID-19 and the Financial Health of US Hospitals. JAMA. 2020;323(21):2127–8. doi: 10.1001/jama.2020.6269 [DOI] [PubMed] [Google Scholar]
  • 11.Essien UR, Eneanya ND, Crews DC. Prioritizing Equity in a Time of Scarcity: The COVID-19 Pandemic. J Gen Intern Med. 2020;35(9):2760–2. doi: 10.1007/s11606-020-05976-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Czypionka T, Kraus M, Mayer S, Röhrling G. Efficiency, ownership, and financing of hospitals: the case of Austria. Health Care Manag Sci. 2014;17(4):331–47. doi: 10.1007/s10729-013-9256-9 [DOI] [PubMed] [Google Scholar]
  • 13.Ministry of Health and Medical Education. COVID-19 2022 [updated 1 Jan 2022. Available from: https://behdasht.gov.ir/.
  • 14.Ghanbari MK, Behzadifar M, Bakhtiari A, Behzadifar M, Azari S, Abolghasem Gorji H, et al. Assessing Iran’s health system according to the COVID-19 strategic preparedness and response plan of the World Health Organization: health policy and historical implications. J Prev Med Hyg. 2021;61(4):E508–E19. doi: 10.15167/2421-4248/jpmh2020.61.4.1613 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Saki M, Ghanbari MK, Behzadifar M, Imani-Nasab MH, Behzadifar M, Azari S, et al. The Impact of the Social Distancing Policy on COVID-19 Incidence Cases and Deaths in Iran from February 2020 to January 2021: Insights from an Interrupted Time Series Analysis. Yale J Biol Med. 2021;94(1):13–21. [PMC free article] [PubMed] [Google Scholar]
  • 16.Sajadi HS, Goodarzi Z, Takian A, Mohamadi E, Olyaeemanesh A, Hosseinzadeh Lotfi F, et al. Assessing the efficiency of Iran health system in making progress towards universal health coverage: a comparative panel data analysis. Cost Eff Resour Alloc. 2020;18:20. doi: 10.1186/s12962-020-00215-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Goudarzi R, Tasavon Gholamhoseini M, Noori Hekmat S, YousefZadeh S, Amini S. The effect of Iran’s health transformation plan on hospital performance: Kerman province. PLoS One. 2021;16(2):e0247155. doi: 10.1371/journal.pone.0247155 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Piroozi B, Rashidian A, Moradi G, Takian A, Ghasri H, Ghadimi T. Out-of-Pocket and Informal Payment Before and After the Health Transformation Plan in Iran: Evidence from Hospitals Located in Kurdistan, Iran. Int J Health Policy Manag. 2017;6(10):573–86. doi: 10.15171/ijhpm.2017.16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Olyaeemanesh A, Behzadifar M, Mousavinejhad N, Behzadifar M, Heydarvand S, Azari S, et al. Iran’s Health System Transformation Plan: A SWOT analysis. Med J Islam Repub Iran. 2018;32:39. doi: 10.14196/mjiri.32.39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gaffney A, Himmelstein DU, Woolhandler S. COVID-19 and US Health Financing: Perils and Possibilities. Int J Health Serv. 2020;50(4):396–407. doi: 10.1177/0020731420931431 [DOI] [PubMed] [Google Scholar]
  • 21.Jamaati H, Dastan F, Esmaeili Dolabi S, Varahram M, Hashemian SM, Nasiri Rayeini S, et al. COVID-19 in Iran: A model for Crisis Management and Current Experience. Iran J Pharm Res. 2020;19(2):1–8. doi: 10.22037/ijpr.2020.113365.14255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nasiri T, Shams L, Hosseini-Shokouh SM. The Economic Effects of COVID-19 on the Hospital Industry in Iran and the World. Ann Ig. 2021;33(1):103–4. doi: 10.7416/ai.2021.2412 [DOI] [PubMed] [Google Scholar]
  • 23.Beiranvand S, Saki M, Behzadifar M, Bakhtiari A, Behzadifar M, Keshvari M, et al. The effect of the Iranian health transformation plan on hospitalization rate: insights from an interrupted time series analysis. BMC Health Serv Res. 2020;20(1):327. doi: 10.1186/s12913-020-05186-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Behzadifar M, Behzadifar M, Saki M, Valipour M, Omidifar R, Iranshahi F, et al. The impact of the "Health Transformation Plan" and related policies on the prevalence rate of cesarean section in Iran: Insights from an interrupted time series analysis. Int J Health Plann Manage. 2020;35(1):339–45. doi: 10.1002/hpm.2916 [DOI] [PubMed] [Google Scholar]
  • 25.Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348–55. doi: 10.1093/ije/dyw098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Komen J, Forslund T, Hjemdahl P, Andersen M, Wettermark B. Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis. Br J Clin Pharmacol. 2017;83(3):642–52. doi: 10.1111/bcp.13150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kontopantelis E, Doran T, Springate DA, Buchan I, Reeves D. Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis. BMJ. 2015:h2750. doi: 10.1136/bmj.h2750 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Linden A, Adams JL. Applying a propensity score-based weighting model to interrupted time series data: improving causal inference in programme evaluation. J Eval Clin Pract. 2011;17(6):1231–8. doi: 10.1111/j.1365-2753.2010.01504.x [DOI] [PubMed] [Google Scholar]
  • 29.Dennis J, Ramsay T, Turgeon AF, Zarychanski R. Helmet legislation and admissions to hospital for cycling related head injuries in Canadian provinces and territories: interrupted time series analysis. BMJ. 2013;346:f2674. doi: 10.1136/bmj.f2674 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Khan JR, Awan N, Islam MM, Muurlink O. Healthcare Capacity, Health Expenditure, and Civil Society as Predictors of COVID-19 Case Fatalities: A Global Analysis. Front Public Health. 2020;8:347. doi: 10.3389/fpubh.2020.00347 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Cavallo JJ, Donoho DA, Forman HP. Hospital capacity and operations in the Coronavirus disease 2019 (COVID-19) pandemic-planning for the nth patient. JAMAHealth Forum. 2020;1(3). [DOI] [PubMed] [Google Scholar]
  • 32.Azari S, Omidi N, Arabloo J, Pourhosseini H, Rezapour A. Resource Utilization and Cost of Hospitalized Patients with COVID-19 in Iran: Rationale and Design of a Protocol. Front Emerg Med. 2020;4(2s):e55. [Google Scholar]
  • 33.Bai G, Zare H. Hospital Cost Structure and the Implications on Cost Management During COVID-19. J Gen Intern Med. 2020;35(9):2807–9. doi: 10.1007/s11606-020-05996-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kazempour-Dizaji M, Sheikhan F, Varahram M, Rouzbahani R, Yousef Vand M, Khosravi B, et al. Changes in a Hospital’s Costs and Revenues Before and After COVID-19: A Case Study of an Iranian Hospital. Health Scope. 2021;10(3):e111620. [Google Scholar]

Decision Letter 0

Edris Hasanpoor

31 Dec 2021

PONE-D-21-30747The effects of the COVID-19 pandemic on public hospital revenues in Lorestan, Iran: insights from an interrupted time-series analysisPLOS ONE

Dear Dr. Behzadifar,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 14 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Edris Hasanpoor

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Abstract

1. Please explain more about data collection in the method section.

2. Please delete million in the ($172,636 million) and replace with (thousand).

3. Please delete the word (dramatically) in the conclusion section.

4. Please replace (covid-19, hospital, health financing, revenue, interrupted time series analysis, health policy, Iran) with old keywords.

Main text:

1. Please update the incidence and mortality rate in the introduction section.

2. Please more explain the difference between services related to the public and private hospitals in Iran.

3. Please mention ethical approval in the method section.

4. Please explain sensitivity analysis in the results section.

5. Figure 3 is low quality, please revise and promote the quality.

6. Please explain more about limitations in the discussion section.

7. Please explain more about tables in the text in the results section.

Reviewer #2: A) The delete the (pandemic, Lorestan and insights from an) in the Title of the manuscript.

B) I think the method section can be improved in the abstract section.

C) What was the role of Iranian government assistance to hospitals?. Add sentences in the introduction section.

D) Explain how to collect hospital revenue in the method section.

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Mar 31;17(3):e0266343. doi: 10.1371/journal.pone.0266343.r002

Author response to Decision Letter 0


11 Feb 2022

Reviewer #1: Abstract

1. Please explain more about data collection in the method section.

Thanks for your comment. We added.

2. Please delete million in the ($172,636 million) and replace with (thousand).

Thanks for your comment. We added.

3. Please delete the word (dramatically) in the conclusion section.

Thanks for your comment. Done.

4. Please replace (covid-19, hospital, health financing, revenue, interrupted time series analysis, health policy, Iran) with old keywords.

Thanks for your comment. Done.

Main text:

1. Please update the incidence and mortality rate in the introduction section.

Thanks for your comment. We added.

2. Please more explain the difference between services related to the public and private hospitals in Iran.

Thanks for your comment. Done.

3. Please mention ethical approval in the method section.

Thanks for your comment. Done.

4. Please explain sensitivity analysis in the results section.

Thanks for your comment. Done.

5. Figure 3 is low quality, please revise and promote the quality.

Thanks for your comment. We added a high-quality figure.

6. Please explain more about limitations in the discussion section.

Thanks for your comment. Done.

7. Please explain more about tables in the text in the results section.

Thanks for your comment. Done.

Reviewer #2:

A) The delete the (pandemic, Lorestan and insights from an) in the Title of the manuscript.

Thanks for your comment. Done.

B) I think the method section can be improved in the abstract section.

Thanks for your comment. Done.

C) What was the role of Iranian government assistance to hospitals?. Add sentences in the introduction section.

Thanks for your comment. Done.

D) Explain how to collect hospital revenue in the method section.

Thanks for your comment. Done.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Edris Hasanpoor

21 Mar 2022

The effect of COVID-19 on public hospital revenues in Iran: An interrupted time-series analysis

PONE-D-21-30747R1

Dear Dr. Behzadifar

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Edris Hasanpoor

Academic Editor

PLOS ONE

Acceptance letter

Edris Hasanpoor

23 Mar 2022

PONE-D-21-30747R1

The effect of COVID-19 on public hospital revenues in Iran: An interrupted time-series analysis

Dear Dr. Behzadifar:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Edris Hasanpoor

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    Data are available upon request to the Corresponding Author and the Ethics Committee of the Lorestan University of Medical Sciences (email: research@lums.ac.ir; tel: 00986633120172); since they may contain potentially sensitive information and are owned by a third-party organization (Lorestan University of Medical Sciences, Iran).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES